HBK Investments’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

HBK Investments’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-15,431	Closed	-$520K	–	1270
2014 Q4	$520K	Sell	15,431 -17,132	-53%	-$605K	0.01%	719
2014 Q3	$1.14M	Buy	32,563 +6,822	+27%	+$234K	0.02%	509
2014 Q2	$846K	Buy	+25,741	New	+$881K	0.02%	561
2014 Q1	–	Sell	-24,574	Closed	-$943K	–	1139
2013 Q4	$943K	Sell	24,574 -21,992	-47%	-$694K	0.02%	475
2013 Q3	$1.28M	Sell	46,566 -11,534	-20%	-$273K	0.02%	403
2013 Q2	$1.22M	Buy	+58,100	New	+$1.13M	0.02%	361

Other funds holding WX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

HBK Investments's WX Position: Q1 2015 in Review

HBK Investments sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q1 2015, closing a stake of 15,431 shares — an estimated $520K sold.

HBK Investments first reported a position in WX in Q2 2013 and held it in 6 quarters. The position peaked at $1.28M in Q3 2013. 147 funds tracked by Wall St. Rank hold WX as of Q1 2015.

HBK Investments reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q1 2015 after selling out during the quarter.
HBK Investments sold 15,431 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q1 2015, an estimated $520K.
HBK Investments first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 6 quarters.
HBK Investments's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $1.28M in Q3 2013.
147 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q1 2015.

Based on HBK Investments's 13F filing for Q1 2015, filed 15 May 2015.